About Us
Alocuro is a medical consultancy with over 30 years of experience supporting general practitioners and medical specialists in the clinical application of validated medical technologies. Our focus is on improving patient outcomes through the integration of best-practice protocols and advanced autologous therapies.
We provide more than medical technologies - we offer a comprehensive service. This includes clinical guidance, workflow design, OH&S support, patient communication materials, and full documentation for streamlined implementation of our platelet-concentrating systems into your practice.
Our regenerative medicine platform utilises autologous blood products that are minimally manipulated to yield a high concentration of platelets. This facilitates targeted tissue regeneration by harnessing the body’s natural healing response - offering a biologically active, patient-derived alternative to synthetic injectables or pharmaceuticals.
Alocuro is 100% Australian owned and operated, with all clinical educators, technical specialists, and procedure trainers based locally. This ensures timely, evidence-informed support tailored to the realities of Australian clinical practice.
Team
Our Medical Liaison team comprises scientifically trained professionals who support the seamless integration of PRP, PRF and BioFiller treatments into clinical practice. We provide comprehensive training for medical and dental practitioners, their teams, and registered nurses and nurse practitioner working under their professional supervision (and within their insured scope of practice).
Standardised best-practice, clinical protocols, patient education materials, consent documentation, and post-procedure care guidelines are provided along with recommended protocols for optimising platelet health and number prior to the procedure.
By ensuring consistency in preparation and administration using Alocuro platelet-concentrating systems, we help practitioners deliver a highly standardised, quality-assured, autologous product, aimed at improving reproducibility and optimising clinical outcomes.
The Alocuro Difference
Alocuro PRP is based on next-generation autologous platelet concentration technology, designed to optimise regenerative outcomes through high-yield, platelet harvesting. The clinical efficacy stems from both the concentration of viable platelets and the volume of growth factors released at the treatment site, supporting predictable outcomes in tissue repair and skin rejuvenation.
What distinguishes the Alocuro PRO-PRP system is its ability to customise PRP & PRF ‘type’ based on clinical indication. Practitioners can selectively adjust:
Platelet dose
Platelet concentration
Leukocyte content
Final PRP volume
Independent pathology testing is regularly conducted in Australia, and confirms a platelet recovery efficiency of ~90%, with consistent performance across patient profiles.
Clinicians also benefit from real-time visualisation of the platelet layer during processing, providing assurance of accurate separation and reproducibility. Visibility to concentrated platelets during every PRP or PRF processing provides clinician confidence and quality assurance.
